Texas Oncology - Austin is a clinical research site located in Austin, Texas, United States 78745.
Crixeo Health Trust Score: 80/100 (GOOD). This profile has not yet been claimed by the site owner.
Texas Oncology - Austin has participated in 13 clinical trials with 10 currently active.
Therapeutic areas: Breast Cancer, HER2-positive Breast Cancer, Metastatic Adenocarcinoma of the Pancreas.
Sponsors: Greenwich LifeSciences, Inc., Seagen, a wholly owned subsidiary of Pfizer, Celcuity Inc.
Trust Score: 80/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Texas Oncology - Austin has a Crixeo Trust Score of 80/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Texas Oncology - Austin has 13 clinical trials on record, with 10 currently active. Their work covers Breast Cancer, HER2-positive Breast Cancer, Metastatic Adenocarcinoma of the Pancreas.
Yes — Texas Oncology - Austin holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.